Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ephrin type-B receptor 1 (EPHB1) is a member of the Eph family of receptor tyrosine kinases that serve as key mediators of cell-cell communication during development and in adult tissues[1][7]. EPHB1 binds to ephrin-B ligands on adjacent cells, initiating a unique form of contact-dependent bidirectional signaling: forward signaling through EPHB1 and reverse signaling through the ephrin ligands[1][9]. This receptor is crucial in axon guidance, particularly in the nervous system where it regulates retinal axon crossing and neural progenitor dynamics. Beyond the nervous system, EPHB1 participates in angiogenesis, cell migration, cell adhesion, and stem cell maintenance, and is implicated in cancer biology and progression[1][3][7]. EPHB1-mediated signaling activates several downstream pathways, including MAPK/ERK and JNK, affecting cell proliferation, polarity, and chemotaxis. Because of its involvement in developmental, neural, and oncogenic processes, EPHB1 and related receptors are being explored as therapeutic targets, particularly in oncology and regenerative medicine[1][4].
Inhibition of kinase domain signaling (small molecules, e.g., kinase inhibitors); Blockade of ephrin ligand-receptor interaction (antibodies or fusion proteins); Induction of receptor internalization and degradation (antibody-drug conjugates, biologics)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ephrin type-B receptor 1 (EPHB1).